Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Cancer Research
|
March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor
Stefan Hart, Oliver M Fischer, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)
|
June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathway
Oliver M Fischer, Stefan Hart, Axel Ullrich
Current Opinion in Chemical Biology
|
August 28, 2003
Beyond Herceptin and Gleevec
Oliver M Fischer, Sylvia Streit, Stefan Hart, et al.
Cellular Signalling
|
February 16, 2006
EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing
Jens E Ruhe, Sylvia Streit, Stefan Hart, et al.
The EMBO Journal
|
May 14, 2003
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Andreas Gschwind, Stefan Hart, Oliver M Fischer, et al.
Molecular and Cellular Biology
|
June 1, 2004
Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor
Oliver M Fischer, Stefan Hart, Andreas Gschwind, et al.
Molecular Pharmaceutics
|
April 26, 2014
Scalable spheroid model of human hepatocytes for hepatitis C infection and replication
Abhishek Ananthanarayanan, Bramasta Nugraha, Miriam Triyatni, et al.
Biological Chemistry
|
September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways
Stefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 11, 2012
SB1578, a novel inhibitor of JAK2, FLT3, and c-Fms for the treatment of rheumatoid arthritis
Babita Madan, Kee Chuan Goh, Stefan Hart, et al.
Oncotarget
|
December 20, 2017
VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim
Nurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Cancer Research
|
March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor
Stefan Hart, Oliver M Fischer, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)
|
June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathway
Oliver M Fischer, Stefan Hart, Axel Ullrich
Current Opinion in Chemical Biology
|
August 28, 2003
Beyond Herceptin and Gleevec
Oliver M Fischer, Sylvia Streit, Stefan Hart, et al.
Cellular Signalling
|
February 16, 2006
EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing
Jens E Ruhe, Sylvia Streit, Stefan Hart, et al.
The EMBO Journal
|
May 14, 2003
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Andreas Gschwind, Stefan Hart, Oliver M Fischer, et al.
Molecular and Cellular Biology
|
June 1, 2004
Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor
Oliver M Fischer, Stefan Hart, Andreas Gschwind, et al.
Molecular Pharmaceutics
|
April 26, 2014
Scalable spheroid model of human hepatocytes for hepatitis C infection and replication
Abhishek Ananthanarayanan, Bramasta Nugraha, Miriam Triyatni, et al.
Biological Chemistry
|
September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways
Stefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 11, 2012
SB1578, a novel inhibitor of JAK2, FLT3, and c-Fms for the treatment of rheumatoid arthritis
Babita Madan, Kee Chuan Goh, Stefan Hart, et al.
Oncotarget
|
December 20, 2017
VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim
Nurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, et al.
Page
of 3